Title
Fracture Behaviour: Nimo Austempered Ductile Iron,Used
Sold by Ergodebooks, an authorized reseller.
Returns accepted within 30 days | support@ergodebooks.com
Shipping Information
- Free Standard Shipping — United States only
- Processing Time: 1–3 business days
- Estimated Delivery: 3–5 business days after dispatch
- Double-boxed, fully insured & discreetly packaged
- Tracking number sent via email once dispatched
- Orders over $250 require signature upon delivery. Taxes calculated at checkout.
Returns & Refund
Returns accepted within 30 days of delivery.
Damaged or Defective Item
Free return shipping + replacement or full refund
Wrong Item Received
Free return shipping + replacement or full refund
Change of Mind
Return shipping at customer's expense · 25% restocking fee applies
There is extensive work on the fracture of steel with ferrite and austenite structure, but little on fracture behaviour of ADI, whose microstructure also comprises austenite and ferrite. The present work is aimed in this direction. The role of austempering tempeature on the fracture behaviour of NiMo austempered ductile iron has been studied. In present work, the fractographic and fractomicrographic features of the fractured specimens austempered at 270, 330, 380 C for 1 hr and broken in tensile test and impact test, respectively, have been studied. The matrix of ADI is a complex mixture of austenite, bainitic ferrite needles with or without carbide particle depends upon the austempering temperature. The matrix of ADI can withstand a certain amount of deformation before fracture during tensile or impact testing, however the graphite nodules in the matrix cannot deform and hence are barrier to matrix deformation and give rise to crack initiation. The crack propagation is influenced by the orientation of bainitic ferrite with respect to load direction, also by the presence of carbide particles inside the needles. Thus producing characteristic features.
⚠️ WARNING (California Proposition 65):
This product may contain chemicals known to the State of California to cause cancer, birth defects, or other reproductive harm.
For more information, please visit www.P65Warnings.ca.gov.